• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Esperion

Quote
anonymous said:
Exactly. Their whole mantra has been about being professional, taking care of people etc but now with the influx of praluent people, the reps who were being recruited hard for a couple of months have been pushed to the curb. Wouldn’t be ironic if the drug wasn’t approved? I think that sort of thing is called karma.
Click to expand...

Im not sure how many Praluent reps will get the jobs? I had what I thought was a solid interview, and have been working within the process well before the layoff happened. All I got was "you'll hear from us within 5 days." First you're told that if you make it to the next level you meet with VP? Director? Then you don't meet the director but are told you're still in consideration? I don't know. There's a lot of good Praluent reps around. If you think it was easy selling that drug, you just don't understand. It was a constant pain in the ass, day in and day out pride swallowing job. I still think it comes down to the basics: do I like this person Im interviewing across the table?

But the process was uncomfortable. Interview questions were odd. Very shallow. Not really matching what needs to happen with the questions being asked in interview. Maybe I won't make it. If not, it will be a bummer, but I'll do something to land on my feet. I always hope the best for people.
 




anonymous said:
Im not sure how many Praluent reps will get the jobs? I had what I thought was a solid interview, and have been working within the process well before the layoff happened. All I got was "you'll hear from us within 5 days." First you're told that if you make it to the next level you meet with VP? Director? Then you don't meet the director but are told you're still in consideration? I don't know. There's a lot of good Praluent reps around. If you think it was easy selling that drug, you just don't understand. It was a constant pain in the ass, day in and day out pride swallowing job. I still think it comes down to the basics: do I like this person Im interviewing across the table?

But the process was uncomfortable. Interview questions were odd. Very shallow. Not really matching what needs to happen with the questions being asked in interview. Maybe I won't make it. If not, it will be a bummer, but I'll do something to land on my feet. I always hope the best for people.
Click to expand...

my sample size is small (under ten) but almost every person that has been offered a position has been praluent... I’m talking 8 of 9. Those may be the only praluent reps that receive offers but from my perspective it seems like the lions shares of the jobs are going to those reps. It is such a high percentage that I don’t know that I would take two days out of my life knowing that the only way that I’ll get the job is if the praluent rep decides not to take it...
 




anonymous said:
my sample size is small (under ten) but almost every person that has been offered a position has been praluent... I’m talking 8 of 9. Those may be the only praluent reps that receive offers but from my perspective it seems like the lions shares of the jobs are going to those reps. It is such a high percentage that I don’t know that I would take two days out of my life knowing that the only way that I’ll get the job is if the praluent rep decides not to take it...
Click to expand...

Hmmm

Im not sure what to think about the whole deal? There was a strange vibe there. I agree with some of the comments above about DM's being called RM's, getting all pumped up for a moderately effective cholesterol pill. They call themselves the lipid company but they only have one drug? The people on the team are from other companies who's agents havent done that well. Case in point-the Repatha person, or the failed Aralez individual. I think they are just hoping for a miracle. Lets hire people with long relationships and hope that gets us what we want.

I've decided Im not going to worry about it. If I get it, fine. If I don't, there's plenty out there.
 




anonymous said:
Hmmm

Im not sure what to think about the whole deal? There was a strange vibe there. I agree with some of the comments above about DM's being called RM's, getting all pumped up for a moderately effective cholesterol pill. They call themselves the lipid company but they only have one drug? The people on the team are from other companies who's agents havent done that well. Case in point-the Repatha person, or the failed Aralez individual. I think they are just hoping for a miracle. Lets hire people with long relationships and hope that gets us what we want.

I've decided Im not going to worry about it. If I get it, fine. If I don't, there's plenty out there.
Click to expand...
 




Don’t kid yourself, this drug is not a blockbuster. If you need a job, take it, but if you are just out fishing for a better opportunity then keep going, there are better opportunities than this.
 








Esperion isn’t budging from their district salary pool- each RSM has to stay within the cash boundaries. That being said, Praluent reps are high to overpriced so Esperion is low balling some and then saying we’ll offer RSU’s to offset. If you’re thinking 140’s think again. Sorry all you MSII from REGN!
 




anonymous said:
Esperion isn’t budging from their district salary pool- each RSM has to stay within the cash boundaries. That being said, Praluent reps are high to overpriced so Esperion is low balling some and then saying we’ll offer RSU’s to offset. If you’re thinking 140’s think again. Sorry all you MSII from REGN!
Click to expand...

If thats accurate Im outta here. Better be at least 140's. If not, go hire the cheap reps with little experience and few relationships. Yeah, see how that works out in the end
 




This company is pissing off a lot of cardiology reps. I thought they were lying when they says they were bringing in three reps per territory. It appears that most territories have three candidates and one is being sent home with a “thanks but no thanks” message, and one is being strung along until the main Vadodara accepts. I hope they realize a lot of the rejected candidates are wondering why exactly they gave this company two days of their lives for this! Put another way, when the inevitable vacancy arises, have they pissed off two of the top reps in that area? The dozen reps that I know that have been rejected are all either upset or pissed. None are thinking “gosh. I’m glad I got the chance to interview.” They are thinking “WTF!” Probably not wise, Esperion!
 




anonymous said:
If thats accurate Im outta here. Better be at least 140's. If not, go hire the cheap reps with little experience and few relationships. Yeah, see how that works out in the end
Click to expand...

OP here, agreed. However, there are folks from AZ and Janssen interviewing that have those same relationships but are significantly cheaper than a Regeneron rep. So...Esperion plays hardball. A 100k bump to 110k + RSU is an easy sell compared to 140k DOWN to 125 + RSU.
 








anonymous said:
This company is pissing off a lot of cardiology reps. I thought they were lying when they says they were bringing in three reps per territory. It appears that most territories have three candidates and one is being sent home with a “thanks but no thanks” message, and one is being strung along until the main Vadodara accepts. I hope they realize a lot of the rejected candidates are wondering why exactly they gave this company two days of their lives for this! Put another way, when the inevitable vacancy arises, have they pissed off two of the top reps in that area? The dozen reps that I know that have been rejected are all either upset or pissed. None are thinking “gosh. I’m glad I got the chance to interview.” They are thinking “WTF!” Probably not wise, Esperion!
Click to expand...

I am pissed, I am one of "those strung along" and then told , we picked someone else. Fuck you to the DM that interviewed me and the rest of the people there. Is the approval date still feb 21?
 








anonymous said:
Esperion isn’t budging from their district salary pool- each RSM has to stay within the cash boundaries. That being said, Praluent reps are high to overpriced so Esperion is low balling some and then saying we’ll offer RSU’s to offset. If you’re thinking 140’s think again. Sorry all you MSII from REGN!
Click to expand...

Don’t forget that there are Sanofi Praluent reps. They are not asking for 140. Many of them are getting spots.
 
















These guys really do seem to be alienating most of the cardiology reps out there. A third of the candidates are feeling like they wasted their time to interview and another third are even more pissed because they are being lead to believe that they are in the running when in fact they are just a backup. Good luck when you have turnover. Sales force expansion? Haha. Good luck with that too...
 




There will be a place with the combination. Repatha will not go quietly they will defend their efficacy. The biggest question when Novartis launches their twice a year injection with a 50% LDL reduction. The Esperion reps will be ready to jump ship to Novartis. Then what?
 




anonymous said:
There will be a place with the combination. Repatha will not go quietly they will defend their efficacy. The biggest question when Novartis launches their twice a year injection with a 50% LDL reduction. The Esperion reps will be ready to jump ship to Novartis. Then what?
Click to expand...

Novartis doesn’t have plans to expand just because of Incliseron. It’s going to be added to the reps with Entresto. If Novartis wants to dominate the lipid market, they should make a bid to buy Esperion.
 




Top Bottom
Back
Quote